In this study, we attempted to determine whether Fas and TRAIL receptors of breast cancer cells are up-regulated by I-131 therapy and whether I-131 therapy can enhance NK cell cytotoxicity in vitro and in vivo. Here, FAS is linked to breast carcinoma.